Versea Diagnostics LLC

FDA Regulatory Profile

Versea Diagnostics LLC appears in FDA public data with 4 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (Z-2410-2021, Class II) was initiated on July 27, 2021.

Summary

Total Recalls
4
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
Z-2410-2021Class IIStatus COVID-19/Flu Rapid Immunoassay for Direct Detection and Differential Diagnosis of SARS-CoV-2,July 27, 2021
Z-2408-2021Class IIFaStep COVID-19 IgG/IgM Rapid Test Device Qualitative detection and differentiation of IgM and IgG July 27, 2021
Z-2407-2021Class IICareStart COVID-19 Antigen Rapid Diagnostic Test for the detection of SARS-CoV-2 Antigen QualitativJuly 27, 2021
Z-2409-2021Class IIHealgen COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) Qualitative detection and dJuly 27, 2021